Anogenital human papillomavirus infection
Therapeutic area
Infectious Disease
Rare disease
No
- Definition
- A sexually transmitted papillary growth caused by the human papillomavirus. It usually arises in the skin and mucous membranes of the perianal region and external genitalia.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Anogenital human papillomavirus infection
- Therapeutic area
- Infectious Disease
- anogenital human papillomavirus infection
- anogenital Human papilloma Virus infection
- condyloma acuminatum
- Disease mechanisms
- Acquired
Sources for recorded values
- Severity
- Mild
- Infectious Disease
- Reproductive Health
Sources for recorded values
- MONDO ID
- MONDO:0005647
- Parent condition
- MONDO:0005161
Related records
Broader conditions (12)
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Human papilloma virus infection
- Infectious disease
- Primary viral infectious disease
- Reproductive system disorder
- Sexually transmitted disease
- Viral infectious disease
- Viral sexually transmitted disease
Narrower conditions (2)
- Anal verrucous carcinoma
- Buschke Lowenstein tumor
Trials (120)
- A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
- A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years
- A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
- A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
- A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
- A Phase â…¢ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
- A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
- A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
- A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
- A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine
- A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASILâ„¢ (V503-006)
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
- A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
- A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)
- A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital Warts
- A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts
- Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial
- Alternate Dosing Schedules Study for HPV Vaccine
- Alternate Dosing Schedules Study for HPV Vaccine (ADS)
- An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old
Approved drugs (3)
- Imiquimod
- Interferon alfa-2B
- Podofilox
Drugs in development (21)
- Ammonium trichlorotellurate Phase 2
- Berdazimer sodium Phase 2
- Cidofovir Phase 1
- Citric acid Phase 2
- Curcumin Phase 2
- Cyclophosphamide Phase 3
- Digoxin Phase 2
- Epigalocatechin gallate Phase 3
- Furosemide Phase 2
- GS-9191 Phase 1
- Hepatitis B virus hbsag surface protein antigen Phase 3
- Ingenol mebutate Phase 2
- Interferon gamma-1B Phase 3
- Nitrogen Phase 2
- Omiganan Phase 2
- Podophyllum resin Phase 3
- Ranpirnase Phase 1
- Sinecatechins Phase 1
- Sodium nitrite Phase 2
- Trichloroacetic acid Phase 2
Other linked drugs (3)
- Human papillomavirus, L1 protein virus like particles
- Hydrogen peroxide
- Peginterferon alfa-2B